NetworkNewsBreaks

TuesdayApr 16, 2024 2:17 pm

NetworkNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) Announces Engagement of Generation IACP

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) today announced that it has engaged Generation IACP Inc. (“IACP”) to provide services as a market maker in compliance with the policies and guidelines of the Canadian Securities Exchange and other applicable legislation. According to the announcement, IACP will receive a fee of C$7,500 plus applicable taxes per month under the agreement, which is for an initial term of six months. The agreement shall be automatically renewed for subsequent six month periods (collectively, the “term’) unless the company provides written notice of termination to IACP at least 30 days…

Continue Reading

TuesdayApr 16, 2024 1:32 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate positive pharmacological effects in the treatment of dry age-related macular degeneration (“AMD”). According to the announcement, in vivo preclinical studies in AMD disease models show that INM-089 delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement. Earlier results showed that INM-089 also preserved retinal function…

Continue Reading

TuesdayApr 16, 2024 1:07 pm

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Reports on Results of Drill Program at Albert Lake Project

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), an exploration company targeting magmatic nickel sulphide discoveries to support the rapidly growing global electric vehicle market, is reporting on the results of the Q1 drill program at the company's wholly owned Albert Lake Project. Key points from the program include that six drillholes have been drilled at the project, totaling 1,386 meters, with Drillhole AL24077 intersecting 0.42% nickel (“Ni”) over an intersection of 2.01 meters; the nickel mineralization is hosted in orthopyroxenite, which is part of the host rock assemblage recognized at the nearby high-grade Ni-Cu+PGE Rottenstone deposit; and the AL24077 nickel…

Continue Reading

TuesdayApr 16, 2024 12:53 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Ships First-Ever FP300 System after Successful FAT, Safety Testing

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, announced that the Factory Acceptance Testing (“FAT”) was successfully completed for the world’s first FuelPositive FP300 system; testing was conducted by FuelPositive’s farmer-partner and advisor, Curtis Hiebert, and was completed on April 10, 2024. Following the successful FAT results, the first FP300 began shipping on April 15, 2024, with the company noting that it will take up to a week for all the components to arrive onsite in Manitoba. According to the announcement, the Hiebert Factory Acceptance Testing included the system being installed the way it would be onsite in…

Continue Reading

TuesdayApr 16, 2024 12:36 pm

NetworkNewsBreaks – SUIC Worldwide Holdings Ltd. (SUIC), I.Hart Group Ink Franchise Authorizations with MONGA Fried Chicken

SUIC Worldwide Holdings (OTC: SUIC), a publicly traded technology company, and its I.Hart Group Taiwan Ltd. have signed a franchise authorization with MONGA(C) Fried Chicken in Japan and in China’s Shandong Province. This is a key step as SUIC and I.Hart evaluate additional high-growth markets in Asia, which offers the largest long-term growth opportunity in the global food industry. According to the announcement, Shandong plans to open 10 stores in the first year and 300 stores within the following five years; the franchise authorizations also increase the companies' presence across 11 countries. With these additions, SUIC and I.Hart Group will have…

Continue Reading

MondayApr 15, 2024 1:21 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company advancing its lead drug candidate, Berubicin, along the pathway to potential regulatory approval and commercialization, recently appointed Amy Mahery to its board of directors. “A biotech commercialization leader, Ms. Mahery has built an illustrious career that spans more than 20 years. During this period, she has gained commercial expertise working with small and large companies in common and rare conditions, as well as across several therapeutic areas… Ms. Mahery lauded CNS Pharmaceuticals and its efforts to fill gaps in areas with high unmet medical needs, such as glioblastoma multiforme (‘GBM’) treatment, saying,…

Continue Reading

MondayApr 15, 2024 1:16 pm

NetworkNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Share CLEAR MIND Study Results in Featured Research Oral Presentation at 2024 AAIC

Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it has been accepted for a Featured Research Oral Presentation to present the company’s CLEAR MIND Phase 2a study results. A Phase 2a randomized clinical trial, CLEAR-MIND is evaluating Lomecel-B(TM) in mild Alzheimer’s disease. In addition to the study results, Longeveron has been accepted for a poster presentation at the 2024 Alzheimer’s Association International Conference (“AAIC”) taking place online and in Philadelphia, Pennsylvania, from July 28 – August 1, 2024. “We are extremely excited to share the full study results of our CLEAR-MIND trial at the…

Continue Reading

MondayApr 15, 2024 12:02 pm

NetworkNewsBreaks – SOBR Safe Inc.’s (NASDAQ: SOBR) SOBRcheck(TM) Delivers Superior Performance vs. Traditional Breathalyzers

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), a disruptive company leveraging advanced alcohol detection approaches and technologies, recently published three case studies that empirically demonstrate the performance of its alcohol screening technology, SOBRcheck(TM), based on customer data, experiences and results. “A stationary identification and alcohol screening/monitoring technology launched in 2021, SOBRcheck detects and instantaneously reports the presence of alcohol emitted through the pores of a fingertip. It is equipped with a biometric identifier that automatically confirms the user’s identity and hardcodes this identification information, as well as the date and time of the screening, into the automatically generated reports, thus boosting reliability,”…

Continue Reading

MondayApr 15, 2024 11:32 am

NetworkNewsBreaks – Reunion Gold Releases Report on Infill Drilling Program at Guyana-Based Oko West Project

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, is reporting on additional drill results from its infill drill program at the Oko West Project. Highlights of the report include Hole D-375 intersecting 60.4 meters (“m”) @ 1.50 grams per tonne of gold (“g/t”) Au, including 6.0 m @ 7.06 g/t, Hole D-381 intersecting 44.9 m @ 2.28 g/t Au, including 18.3 m @ 4.38 g/t Au and Hole D-389 intersecting 21.6 m @4.00 g/t Au, including 4.0m @ 17.67 g/t Au. According to the report, these results continue to expand the core of high-grade…

Continue Reading

MondayApr 15, 2024 10:52 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Update on Celly Nu Investment

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, is reporting on its investment in Celly Nutrition Corp. According to the report, FSA entered into a loan-amending agreement with Celly Nu that increased the principal of a previously announced term loan by $300,000, from $1 million to $1.3 million. Celly Nu is a privately held Canadian company launching an innovative beverage product that can assist in expediting alcohol metabolism and faster recovery from alcohol consumption. The announcement noted that the interest…

Continue Reading